Fidelity Investments’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5705 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5642 |
|
|
2023
Q3 | – | Sell |
-9
| Closed | -$388 | – | 5512 |
|
|
2023
Q2 | $701 | Sell |
9
-5
| -36% | -$404 | ﹤0.01% | 4763 |
|
|
2023
Q1 | $1.31K | Buy |
14
+1
| +8% | +$95 | ﹤0.01% | 4705 |
|
|
2022
Q4 | $1.25K | Sell |
13
-4
| -24% | -$580 | ﹤0.01% | 4608 |
|
|
2022
Q3 | $4K | Sell |
17
-13
| -43% | -$3.78K | ﹤0.01% | 4416 |
|
|
2022
Q2 | $6K | Buy |
30
+25
| +500% | +$2.39K | ﹤0.01% | 4278 |
|
|
2022
Q1 | $1K | Buy |
+5
| New | +$642 | ﹤0.01% | 4849 |
|
|
2020
Q3 | – | Sell |
-20
| Closed | -$10K | – | 3988 |
|
|
2020
Q2 | $10K | Buy |
+20
| New | +$8.92K | ﹤0.01% | 3121 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | -$1K | – | 4249 |
|
|
2019
Q4 | $1K | Sell |
1
-3
| -75% | -$2.06K | ﹤0.01% | 3691 |
|
|
2019
Q3 | $3K | Hold |
4
| – | – | ﹤0.01% | 3508 |
|
|
2019
Q2 | $3K | Sell |
4
-1
| -20% | -$688 | ﹤0.01% | 3482 |
|
|
2019
Q1 | $3K | Buy |
+5
| New | +$2.09K | ﹤0.01% | 3377 |
|
|
2018
Q4 | – | Sell |
-3,431
| Closed | -$1.65M | – | 4136 |
|
|
2018
Q3 | $1.65M | Buy |
+3,431
| New | +$1.47M | ﹤0.01% | 2402 |
|
|
2016
Q3 | – | Sell |
-13,032
| Closed | -$10.7M | – | 2694 |
|
|
2016
Q2 | $10.7M | Buy |
+13,032
| New | +$14.2M | ﹤0.01% | 1930 |
|
|
2016
Q1 | – | Sell |
-5,537
| Closed | -$6.9M | – | 2733 |
|
|
2015
Q4 | $6.9M | Buy |
5,537
+4,172
| +306% | +$6.9M | ﹤0.01% | 2103 |
|
|
2015
Q3 | $1.84M | Sell |
1,365
-10,904
| -89% | -$18M | ﹤0.01% | 2439 |
|
|
2015
Q2 | $22.1M | Buy |
12,269
+1,903
| +18% | +$2.95M | ﹤0.01% | 1689 |
|
|
2015
Q1 | $16.7M | Buy |
+10,366
| New | +$15.4M | ﹤0.01% | 1794 |
|
|
2014
Q4 | – | Sell |
-20,898
| Closed | -$8.28M | – | 2840 |
|
|
2014
Q3 | $8.28M | Sell |
20,898
-8,526
| -29% | -$4.11M | ﹤0.01% | 2075 |
|
|
2014
Q2 | $17.8M | Sell |
29,424
-20,296
| -41% | -$11.3M | ﹤0.01% | 1844 |
|
|
2014
Q1 | $34.2M | Sell |
49,720
-466
| -0.9% | -$312K | ﹤0.01% | 1502 |
|
|
2013
Q4 | $32.7M | Buy |
50,186
+7,994
| +19% | +$4.76M | ﹤0.01% | 1518 |
|
|
2013
Q3 | $25M | Sell |
42,192
-507
| -1% | -$228K | ﹤0.01% | 1605 |
|
|
2013
Q2 | $13.4M | Buy |
+42,699
| New | +$11.9M | ﹤0.01% | 1832 |
|
Other funds holding TCRT
MP
CB
ACM
Fidelity Investments's TCRT Position: Q1 2024 in Review
Fidelity Investments held its Alaunos Therapeutics (TCRT) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5705.
Fidelity Investments first reported a position in TCRT in Q2 2013 and has held it in 23 quarters since. The position peaked at $34.2M in Q1 2014. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.
- Fidelity Investments held 0 shares of Alaunos Therapeutics worth $0 as of Q1 2024.
- Fidelity Investments left its Alaunos Therapeutics share count unchanged in Q1 2024.
- Alaunos Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2024, its #5705 holding.
- Fidelity Investments first reported a position in Alaunos Therapeutics in Q2 2013 and has held it in 23 quarters since.
- Fidelity Investments's Alaunos Therapeutics position peaked at $34.2M in Q1 2014.
- 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.
Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.